title: Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation.
abstract: BACKGROUND
  Metformin, an oral biguanide traditionally used for the treatment of type 2 diabetes, is widely used for the management of polycystic ovary syndrome (PCOS)-related anovulation. Because of the significant prevalence of insulin resistance and glucose intolerance in PCOS patients, and their putative role in ovulatory dysfunction, the use of metformin was touted as a means to improve ovulatory function and reproductive outcomes in PCOS patients. To date, there has been inconsistent evidence to demonstrate a favorable effect of metformin on oocyte quality and competence in women with PCOS. Given the heterogeneous nature of this disorder, we hypothesized that metformin may be beneficial in mice with aberrant metabolic characteristics similar to a significant number of PCOS patients. The aim of this study was to gain insight into the in vitro and in vivo effects of metformin on oocyte development and ovulatory function.
  
  
  METHODS
  We utilized metformin treatment in the transgenic ob/ob and db/db mutant murine models which demonstrate metabolic and reproductive characteristics similar to women with PCOS.
  
  
  RESULTS
  Metformin did not improve in vitro oocyte maturation nor did it have an appreciable effect on in vitro granulosa cell luteinization (progesterone production) in any genotype studied. Although both mutant strains have evidence of hyperandrogenemia, anovulation, and hyperinsulinemia, only db/db mice treated with metformin had a greater number of mature oocytes and total overall oocytes compared to control. There was no observed impact on body mass, or serum glucose and androgens in any genotype.
  
  
  CONCLUSIONS
  Our data provide evidence to suggest that metformin may optimize ovulatory performance in mice with a specific reproductive and metabolic phenotype shared by women with PCOS. The only obvious difference between the mutant murine models is that the db/db mice have elevated leptin levels raising the questions of whether their response to metformin is related to elevated leptin levels and/or if a subset of PCOS women with hyperleptinemia may be responsive to metformin therapy. Further study is needed to better define a subset of women with PCOS that may be responsive to metformin.
authors: Vincent Center for Reproductive Biology, Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA. astyer@partners.org.
authors: Mary E
authors: ME
authors: Sabatini
authors: Lankai
authors: L
authors: Guo
authors: Maureen P
authors: MP
authors: Lynch
authors: Joseph O
authors: JO
authors: Doyle
authors: Hojoon
authors: H
authors: Lee
authors: Bo R
authors: BR
authors: Rueda
authors: Aaron K
authors: AK
authors: Styer
references: Endocrinology. 2009 Sep;150(9):4425-36
references: 19470707
references: J Clin Endocrinol Metab. 1985 Dec;61(6):1126-32
references: 3932449
references: Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4023-8
references: 10760274
references: BMJ. 2003 Oct 25;327(7421):951-3
references: 14576245
references: Biol Reprod. 2007 Apr;76(4):589-97
references: 17167165
references: Dev Biol. 2006 Mar 15;291(2):227-38
references: 16443210
references: Behav Genet. 2002 Nov;32(6):435-43
references: 12467341
references: Endocr Rev. 1997 Dec;18(6):774-800
references: 9408743
references: Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006105
references: 19370625
references: Arch Pharm Res. 2004 Jul;27(7):806-10
references: 15357011
references: J Clin Endocrinol Metab. 2004 Nov;89(11):5454-61
references: 15531497
references: J Biol Chem. 2004 Mar 26;279(13):12005-8
references: 14742438
references: Biochem J. 1998 Nov 1;335 ( Pt 3):533-9
references: 9794792
references: Clin Endocrinol (Oxf). 1989 Feb;30(2):177-84
references: 2532984
references: Biol Reprod. 2006 Sep;75(3):342-51
references: 16760380
references: Folia Histochem Cytobiol. 2009;47(2):323-8
references: 19995720
references: Semin Reprod Endocrinol. 1997 May;15(2):111-22
references: 9165656
references: Biol Reprod. 2007 Mar;76(3):368-78
references: 17123942
references: J Clin Invest. 2001 Oct;108(8):1167-74
references: 11602624
references: Best Pract Res Clin Endocrinol Metab. 2006 Jun;20(2):193-205
references: 16772151
references: Diabetologia. 1973 Aug;9(4):287-93
references: 4588246
references: Hum Reprod. 2010 Apr;25(4):1005-13
references: 20106839
references: Endocrinol Metab Clin North Am. 1999 Jun;28(2):361-78
references: 10352923
references: Am J Obstet Gynecol. 2004 Sep;191(3):713-7
references: 15467530
references: J Clin Endocrinol Metab. 2009 Feb;94(2):670-7
references: 19001513
references: Semin Reprod Med. 2008 Jan;26(1):22-34
references: 18181079
references: Minerva Ginecol. 2004 Feb;56(1):63-79
references: 14973411
references: Nature. 2004 Apr 1;428(6982):569-74
references: 15058305
references: Hum Reprod. 2004 Jan;19(1):41-7
references: 14688154
references: Nature. 2002 Jan 17;415(6869):339-43
references: 11797013
references: Hum Reprod. 2006 Apr;21(4):924-9
references: 16361289
references: BMJ. 2006 Jun 24;332(7556):1485
references: 16769748
references: Endocrinology. 2009 Oct;150(10):4794-801
references: 19574398
references: Mol Reprod Dev. 2007 Aug;74(8):1021-34
references: 17290417
references: Semin Reprod Med. 2008 Jan;26(1):14-21
references: 18181078
references: Metabolism. 1994 May;43(5):647-54
references: 8177055
references: Endocrinology. 2011 Mar;152(3):1112-8
references: 21209024
references: J Clin Endocrinol Metab. 1987 Sep;65(3):499-507
references: 3305551
references: Endocrinology. 2007 Aug;148(8):3781-91
references: 17495003
references: Reprod Biol Endocrinol. 2003 Feb 06;1:11
references: 12646064
references: Obstet Gynecol. 2008 Apr;111(4):959-68
references: 18378757
references: Hum Reprod. 2005 Sep;20(9):2391-5
references: 15932917
references: Reprod Biomed Online. 2008 Mar;16(3):327-35
references: 18339252
references: Nat Med. 2002 Nov;8(11):1288-95
references: 12368907
references: N Engl J Med. 2005 Mar 24;352(12):1223-36
references: 15788499
references: Reproduction. 2010 Feb;139(2):409-18
references: 19906888
references: J Clin Endocrinol Metab. 2007 Sep;92(9):3498-503
references: 17595241
references: Hum Fertil (Camb). 2010 Sep;13(3):134-42
references: 20849198
references: N Engl J Med. 2007 Feb 8;356(6):551-66
references: 17287476
references: Diabetologia. 1978 Mar;14(3):141-8
references: 350680
references: J Clin Endocrinol Metab. 1996 Mar;81(3):1003-8
references: 8772565
references: J Clin Endocrinol Metab. 2005 Apr;90(4):1929-35
references: 15623819
references: Science. 2005 Dec 9;310(5754):1642-6
references: 16308421
references: Int J Gynaecol Obstet. 2001 Sep;74(3):261-7
references: 11543750
references: J Clin Endocrinol Metab. 2008 Mar;93(3):792-800
references: 18000088